Clinical Trials Logo

Acute Bacterial Conjunctivitis clinical trials

View clinical trials related to Acute Bacterial Conjunctivitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT01227915 Not yet recruiting - Clinical trials for Acute Bacterial Conjunctivitis

Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis

Start date: February 2011
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate, through clinical parameters, the comparative efficacy between topical Tobracort ® (tobramycin 0.3% dexamethasone + 1% - Chemistry Lab Union) and TOBRADEX ® (tobramycin 0.3% dexamethasone + 1 % - Alcon Lab), using the percentage of improvement (sustained response rate) at the end of treatment.

NCT ID: NCT00348348 Completed - Clinical trials for Acute Bacterial Conjunctivitis

A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis

Start date: June 2006
Phase: Phase 3
Study type: Interventional

This is a study to investigate a novel drug candidate for the treatment of bacterial conjunctivitis.

NCT ID: NCT00347932 Completed - Clinical trials for Acute Bacterial Conjunctivitis

A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.

Start date: June 2006
Phase: Phase 3
Study type: Interventional

Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis.